Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate

Arch Gynecol Obstet. 1994;255(2):91-4. doi: 10.1007/BF02391803.

Abstract

A 32-year infertile Japanese woman suffered from endometrial cancer, which was treated with repeated endometrial curettage and medroxyprogesterone acetate for 6 months. The patient then became pregnant and was delivered of a live-born male infant at 37 weeks gestation by cesarean section for placenta previa. At cesarean section there were no abnormal findings in the uterine cavity or other pelvic organs.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / surgery
  • Adult
  • Cesarean Section
  • Combined Modality Therapy
  • Dilatation and Curettage
  • Endometrial Neoplasms / drug therapy*
  • Endometrial Neoplasms / surgery
  • Female
  • Humans
  • Medroxyprogesterone Acetate / therapeutic use*
  • Placenta Previa / surgery
  • Pregnancy
  • Pregnancy Outcome*

Substances

  • Medroxyprogesterone Acetate